1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
3
|
Smyth EC, Nilsson M, Grabsch HI, van
Grieken NC and Lordick F: Gastric cancer. Lancet. 396:635–648.
2020. View Article : Google Scholar : PubMed/NCBI
|
4
|
Fu M, Gu J, Jiang P, Qian H, Xu W and
Zhang X: Exosomes in gastric cancer: Roles, mechanisms, and
applications. Mol Cancer. 18:412019. View Article : Google Scholar : PubMed/NCBI
|
5
|
Dong Z, Sun X, Xu J, Han X, Xing Z, Wang
D, Ge J, Meng L and Xu X: Serum membrane type 1-matrix
metalloproteinase (MT1-MMP) mRNA protected by exosomes as a
potential biomarker for gastric cancer. Med Sci Monit.
25:7770–7783. 2019. View Article : Google Scholar : PubMed/NCBI
|
6
|
Wang J, Liu Y, Sun W, Zhang Q, Gu T and Li
G: Plasma exosomes as novel biomarker for the early diagnosis of
gastric cancer. Cancer Biomark. 21:805–812. 2018. View Article : Google Scholar : PubMed/NCBI
|
7
|
Hernández A, Arab JP, Reyes D, Lapitz A,
Moshage H, Bañales JM and Arrese M: Extracellular vesicles in
NAFLD/ALD: From pathobiology to therapy. Cells. 9:8172020.
View Article : Google Scholar
|
8
|
Martinez RM, Hauser R, Liang L, Mansur A,
Adir M, Dioni L, Racowsky C, Bollati V, Baccarelli AA and
Machtinger R: Urinary concentrations of phenols and phthalate
metabolites reflect extracellular vesicle microRNA expression in
follicular fluid. Environ Int. 123:20–28. 2019. View Article : Google Scholar : PubMed/NCBI
|
9
|
Jun JH, Kim JY, Choi JH, Lim JY, Kim K and
Kim GJ: Exosomes from placenta-derived mesenchymal stem cells are
involved in liver regeneration in hepatic failure induced by bile
duct ligation. Stem Cells Int. 2020:54857382020. View Article : Google Scholar : PubMed/NCBI
|
10
|
Gholami L, Nooshabadi VT, Shahabi S,
Jazayeri M, Tarzemany R, Afsartala Z and Khorsandi K: Extracellular
vesicles in bone and periodontal regeneration: Current and
potential therapeutic applications. Cell Biosci. 11:162021.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Samanta S, Rajasingh S, Drosos N, Zhou Z,
Dawn B and Rajasingh J: Exosomes: new molecular targets of
diseases. Acta Pharmacol Sin. 39:501–513. 2018. View Article : Google Scholar : PubMed/NCBI
|
12
|
Maacha S, Bhat AA, Jimenez L, Raza A,
Haris M, Uddin S and Grivel JC: Extracellular vesicles-mediated
intercellular communication: Roles in the tumor microenvironment
and anti-cancer drug resistance. Mol Cancer. 18:552019. View Article : Google Scholar : PubMed/NCBI
|
13
|
Abd Elmageed ZY, Yang Y, Thomas R, Ranjan
M, Mondal D, Moroz K, Fang Z, Rezk BM, Moparty K, Sikka SC, et al:
Neoplastic Reprogramming of Patient-Derived Adipose Stem Cells by
Prostate Cancer Cell-Associated Exosomes. Stem Cells. 32:983–997.
2014. View Article : Google Scholar : PubMed/NCBI
|
14
|
Zhang X, Shi H, Yuan X, Jiang P, Qian H
and Xu W: Tumor-derived exosomes induce N2 polarization of
neutrophils to promote gastric cancer cell migration. Mol Cancer.
17:1462018. View Article : Google Scholar : PubMed/NCBI
|
15
|
Mulcahy LA, Pink RC and Carter DR: Routes
and mechanisms of extracellular vesicle uptake. J Extracell
Vesicles. 3:246412014. View Article : Google Scholar
|
16
|
Huang T, Song C, Zheng L, Xia L, Li Y and
Zhou Y: The roles of extracellular vesicles in gastric cancer
development, microenvironment, anti-cancer drug resistance, and
therapy. Mol Cancer. 18:622019. View Article : Google Scholar : PubMed/NCBI
|
17
|
Xu R, Rai A, Chen M, Suwakulsiri W,
Greening DW and Simpson RJ: Extracellular vesicles in
cancer-implications for future improvements in cancer care. Nat Rev
Clin Oncol. 15:617–638. 2018. View Article : Google Scholar : PubMed/NCBI
|
18
|
Lin MT, Song HJ and Ding XY: Long
non-coding RNAs involved in metastasis of gastric cancer. World J
Gastroenterol. 24:3724–3737. 2018. View Article : Google Scholar : PubMed/NCBI
|
19
|
Jiang S, Cheng SJ, Ren LC, Wang Q, Kang
YJ, Ding Y, Hou M, Yang XX, Lin Y, Liang N and Gao G: An expanded
landscape of human long noncoding RNA. Nucleic Acids Res.
47:7842–7856. 2019. View Article : Google Scholar : PubMed/NCBI
|
20
|
Zhou X, Chen H, Zhu L, Hao B, Zhang W, Hua
J, Gu H, Jin W and Zhang G: Helicobacter pylori infection related
long noncoding RNA (lncRNA) AF147447 inhibits gastric cancer
proliferation and invasion by targeting MUC2 and up-regulating
miR-34c. Oncotarget. 7:82770–82782. 2016. View Article : Google Scholar : PubMed/NCBI
|
21
|
Zhuo W, Liu Y, Li S, Guo D, Sun Q, Jin J,
Rao X, Li M, Sun M, Jiang M, et al: Long noncoding RNA GMAN,
up-regulated in gastric cancer tissues, is associated with
metastasis in patients and promotes translation of ephrin A1 by
competitively binding GMAN-AS. Gastroenterology. 156:676–691.e11.
2019. View Article : Google Scholar : PubMed/NCBI
|
22
|
Yang L, Peng X, Li Y, Zhang X, Ma Y, Wu C,
Fan Q, Wei S, Li H and Liu J: Long non-coding RNA HOTAIR promotes
exosome secretion by regulating RAB35 and SNAP23 in hepatocellular
carcinoma. Mol Cancer. 18:782019. View Article : Google Scholar : PubMed/NCBI
|
23
|
Li Q, Shao Y, Zhang X, Zheng T, Miao M,
Qin L, Wang B, Ye G, Xiao B and Guo J: Plasma long noncoding RNA
protected by exosomes as a potential stable biomarker for gastric
cancer. Tumour Biol. 36:2007–2012. 2015. View Article : Google Scholar : PubMed/NCBI
|
24
|
Lin LY, Yang L, Zeng Q, Wang L, Chen ML,
Zhao ZH, Ye GD, Luo QC, Lv PY, Guo QW, et al: Tumor-originated
exosomal lncUEGC1 as a circulating biomarker for early-stage
gastric cancer. Mol Cancer. 17:842018. View Article : Google Scholar : PubMed/NCBI
|
25
|
Zhao R and Zhang Y, Zhang X, Yang Y, Zheng
X, Li X, Liu Y and Zhang Y: Exosomal long noncoding RNA HOTTIP as
potential novel diagnostic and prognostic biomarker test for
gastric cancer. Mol Cancer. 17:682018. View Article : Google Scholar : PubMed/NCBI
|
26
|
Arunkumar G, Murugan AK, Prasanna
Srinivasa Rao H, Subbiah S, Rajaraman R and Munirajan AK: Long
non-coding RNA CCAT1 is overexpressed in oral squamous cell
carcinomas and predicts poor prognosis. Biomed Rep. 6:455–462.
2017. View Article : Google Scholar : PubMed/NCBI
|
27
|
Mizrahi I, Mazeh H, Grinbaum R, Beglaibter
N, Wilschanski M, Pavlov V, Adileh M, Stojadinovic A, Avital I,
Gure AO, et al: Colon cancer associated transcript-1 (CCAT1)
expression in adenocarcinoma of the stomach. J Cancer. 6:105–110.
2015. View Article : Google Scholar : PubMed/NCBI
|
28
|
Chen S, Liu Y, Wang Y and Xue Z: LncRNA
CCAT1 promotes colorectal cancer tumorigenesis via a
miR-181b-5p/TUSC3 axis. Onco Targets Ther. 12:9215–9225. 2019.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Deng L, Yang SB, Xu FF and Zhang JH: Long
noncoding RNA CCAT1 promotes hepatocellular carcinoma progression
by functioning as let-7 sponge. J Exp Clin Cancer Res. 34:182015.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Zhang C, Wang W, Lin J, Xiao J and Tian Y:
lncRNA CCAT1 promotes bladder cancer cell proliferation, migration
and invasion. Int Braz J Urol. 45:549–559. 2019. View Article : Google Scholar : PubMed/NCBI
|
31
|
Xin Y, Li Z, Shen J, Chan MT and Wu WK:
CCAT1: A pivotal oncogenic long non-coding RNA in human cancers.
Cell Prolif. 49:255–260. 2016. View Article : Google Scholar : PubMed/NCBI
|
32
|
Liu Z, Chen Q and Hann SS: The functions
and oncogenic roles of CCAT1 in human cancer. Biomed Pharmacother.
115:1089432019. View Article : Google Scholar : PubMed/NCBI
|
33
|
Shen H, Wang L, Xiong J, Ren C, Gao C,
Ding W, Zhu D, Ma D and Wang H: Long non-coding RNA CCAT1 promotes
cervical cancer cell proliferation and invasion by regulating the
miR-181a-5p/MMP14 axis. Cell Cycle. 18:1110–1121. 2019. View Article : Google Scholar : PubMed/NCBI
|
34
|
You Z, Liu C, Wang C, Ling Z, Wang Y, Wang
Y, Zhang M, Chen S, Xu B, Guan H and Chen M: LncRNA CCAT1 promotes
prostate cancer cell proliferation by interacting with DDX5 and
MIR-28-5P. Mol Cancer Ther. 18:2469–2479. 2019. View Article : Google Scholar : PubMed/NCBI
|
35
|
Abedini P, Fattahi A, Agah S, Talebi A,
Beygi AH, Amini SM, Mirzaei A and Akbari A: Expression analysis of
circulating plasma long noncoding RNAs in colorectal cancer: The
relevance of lncRNAs ATB and CCAT1 as potential clinical hallmarks.
J Cell Physiol. 234:22028–22033. 2019. View Article : Google Scholar : PubMed/NCBI
|
36
|
Li Y, Zhu G, Ma Y and Qu H: lncRNA CCAT1
contributes to the growth and invasion of gastric cancer via
targeting miR-219-1. J Cell Biochem. 120:19457–19468. 2019.
View Article : Google Scholar : PubMed/NCBI
|
37
|
Xie Y, Dang W, Zhang S, Yue W, Yang L,
Zhai X, Yan Q and Lu J: The role of exosomal noncoding RNAs in
cancer. Mol Cancer. 18:372019. View Article : Google Scholar : PubMed/NCBI
|
38
|
Barbagallo C, Brex D, Caponnetto A,
Cirnigliaro M, Scalia M, Magnano A, Caltabiano R, Barbagallo D,
Biondi A, Cappellani A, et al: LncRNA UCA1, upregulated in CRC
biopsies and downregulated in serum exosomes, controls mRNA
expression by RNA-RNA interactions. Mol Ther Nucleic Acids.
12:229–241. 2018. View Article : Google Scholar : PubMed/NCBI
|
39
|
Galamb O, Barták BK, Kalmár A, Nagy ZB,
Szigeti KA, Tulassay Z, Igaz P and Molnár B: Diagnostic and
prognostic potential of tissue and circulating long non-coding RNAs
in colorectal tumors. World J Gastroenterol. 25:5026–5048. 2019.
View Article : Google Scholar : PubMed/NCBI
|
40
|
Amin MB, Greene FL, Edge SB, Compton CC,
Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and
Winchester DP: The eighth edition AJCC cancer staging manual:
Continuing to build a bridge from a population-based to a more
‘personalized’ approach to cancer staging. CA Cancer J Clin.
67:93–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
41
|
Zhang J, Arends RH, Kubiak RJ, Roskos LK,
Liang M, Lee N, Chen CC and Yang H: A new method for identification
of outliers in immunogenicity assay cut point data. J Immunol
Methods. 484-485:1128172020. View Article : Google Scholar : PubMed/NCBI
|
42
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
43
|
Li S, Li Y, Chen B, Zhao J, Yu S, Tang Y,
Zheng Q, Li Y, Wang P, He X and Huang S: ExoRBase: A database of
circRNA, lncRNA and mRNA in human blood exosomes. Nucleic Acids
Res. 46(D1): D106–D112. 2018. View Article : Google Scholar
|
44
|
Arita T, Ichikawa D, Konishi H, Komatsu S,
Shiozaki A, Shoda K, Kawaguchi T, Hirajima S, Nagata H, Kubota T,
et al: Circulating long non-coding RNAs in plasma of patients with
gastric cancer. Anticancer Res. 33:3185–3193. 2013.PubMed/NCBI
|
45
|
Zhong G, Wang K, Li J, Xiao S, Wei W and
Liu J: Determination of serum exosomal H19 as a noninvasive
biomarker for breast cancer diagnosis. Onco Targets Ther.
13:2563–2571. 2020. View Article : Google Scholar : PubMed/NCBI
|
46
|
Li N, Li J, Mi Q, Xie Y, Li P, Wang L,
Binang H, Wang Q, Wang Y, Chen Y, et al: Long non-coding RNA
ADAMTS9-AS1 suppresses colorectal cancer by inhibiting the
Wnt/β-catenin signalling pathway and is a potential diagnostic
biomarker. J Cell Mol Med. 24:11318–11329. 2020. View Article : Google Scholar : PubMed/NCBI
|
47
|
Wang J, Pu J, Zhang Y, Yao T, Luo Z, Li W,
Xu G, Liu J, Wei W and Deng Y: Exosome-transmitted long non-coding
RNA SENP3-EIF4A1 suppresses the progression of hepatocellular
carcinoma. Aging (Albany NY). 12:11550–11567. 2020. View Article : Google Scholar : PubMed/NCBI
|
48
|
Taylor DD and Gercel-Taylor C: MicroRNA
signatures of tumor-derived exosomes as diagnostic biomarkers of
ovarian cancer. Gynecol Oncol. 110:13–21. 2008. View Article : Google Scholar : PubMed/NCBI
|
49
|
Scavo MP, Cigliano A, Depalo N, Fanizza E,
Bianco MG, Denora N, Laquintana V, Curri ML, Lorusso D, Lotesoriere
C, et al: Frizzled-10 extracellular vesicles plasma concentration
is associated with tumoral progression in patients with colorectal
and gastric cancer. J Oncol. 2019:27159682019. View Article : Google Scholar : PubMed/NCBI
|
50
|
Chung KY, Quek JM, Neo SH and Too HP:
Polymer-based precipitation of extracellular vesicular miRNAs from
serum improve gastric cancer miRNA biomarker performance. J Mol
Diagn. 22:610–618. 2020. View Article : Google Scholar : PubMed/NCBI
|
51
|
Pegtel DM and Gould SJ: Exosomes. Annu Rev
Biochem. 88:487–514. 2019. View Article : Google Scholar : PubMed/NCBI
|
52
|
Xu R, Greening DW, Zhu HJ, Takahashi N and
Simpson RJ: Extracellular vesicle isolation and characterization:
Toward clinical application. J Clin Invest. 126:1152–1162. 2016.
View Article : Google Scholar : PubMed/NCBI
|
53
|
Tkach M and Théry C: Communication by
extracellular vesicles: Where we are and where we need to go? Cell.
164:1226–1232. 2016. View Article : Google Scholar : PubMed/NCBI
|
54
|
Kalluri R and LeBleu VS: The biology,
function, and biomedical applications of exosomes. Science.
367:eaau69772020. View Article : Google Scholar : PubMed/NCBI
|
55
|
Wu L, Zhang X, Zhang B, Shi H, Yuan X, Sun
Y, Pan Z, Qian H and Xu W: Exosomes derived from gastric cancer
cells activate NF-κB pathway in macrophages to promote cancer
progression. Tumour Biol. 37:12169–12180. 2016. View Article : Google Scholar : PubMed/NCBI
|
56
|
Kinoshita H, Hayakawa Y and Koike K:
Metaplasia in the stomach-precursor of gastric cancer? Int J Mol
Sci. 18:20632017. View Article : Google Scholar : PubMed/NCBI
|
57
|
Yang F, Xue X, Bi J, Zheng L, Zhi K, Gu Y
and Fang G: Long noncoding RNA CCAT1, which could be activated by
c-Myc, promotes the progression of gastric carcinoma. J Cancer Res
Clin Oncol. 139:437–445. 2013. View Article : Google Scholar : PubMed/NCBI
|
58
|
Li N, Jiang K, Fang LP, Yao LL and Yu Z:
Knockdown of long noncoding RNA CCAT1 inhibits cell growth,
invasion and peritoneal metastasis via downregulation of Bmi-1 in
gastric cancer. Neoplasma. 65:736–744. 2018. View Article : Google Scholar : PubMed/NCBI
|
59
|
Zhao W, Song M, Zhang J, Kuerban M and
Wang H: Combined identification of long non-coding RNA CCAT1 and
HOTAIR in serum as an effective screening for colorectal carcinoma.
Int J Clin Exp Pathol. 8:14131–14140. 2015.PubMed/NCBI
|
60
|
Li S, Zhang M, Zhang H, Hu K, Cai C, Wang
J, Shi L, Ma P, Xu Y and Zheng P: Exosomal long noncoding RNA
lnc-GNAQ-6:1 may serve as a diagnostic marker for gastric cancer.
Clin Chim Acta. 501:252–257. 2020. View Article : Google Scholar : PubMed/NCBI
|
61
|
Tong YS, Wang XW, Zhou XL, Liu ZH, Yang
TX, Shi WH, Xie HW, Lv J, Wu QQ and Cao XF: Identification of the
long non-coding RNA POU3F3 in plasma as a novel biomarker for
diagnosis of esophageal squamous cell carcinoma. Mol Cancer.
14:32015. View Article : Google Scholar : PubMed/NCBI
|
62
|
Zhang Z, Xie H, Liang D, Huang L, Liang F,
Qi Q and Yang X: Long non-coding RNA CCAT1 as a diagnostic and
prognostic molecular marker in various cancers: A meta-analysis.
Oncotarget. 9:23695–23703. 2018. View Article : Google Scholar : PubMed/NCBI
|
63
|
Ozawa T, Matsuyama T, Toiyama Y, Takahashi
N, Ishikawa T, Uetake H, Yamada Y, Kusunoki M, Calin G and Goel A:
CCAT1 and CCAT2 long noncoding RNAs, located within the 8q.24.21
‘gene desert’, serve as important prognostic biomarkers in
colorectal cancer. Ann Oncol. 28:1882–1888. 2017. View Article : Google Scholar : PubMed/NCBI
|